Welcome
PPM

Abstract

 
  Search

 


 

 

 






Self-Protection Against "Off-Label" Lawsuits

by Forest Tennant MD, DrPH

 “Off-label” use of pharmaceuticals refers to a usage or dosage other than that specifically listed in the package insert (PI). When a drug is approved for commercial marketing by the US Food and Drug Administration (FDA), it does so after the maker of the drug prepares a PI listing the drug’s recommended indications and dosage, as well as possible complications. PI’s are routinely published in the Physician’s Desk Reference (PDR), and they accompany all bulk shipments of the drug which are stocked in pharmacies. The actual label on a prescription bottle will only contain a fraction of the PI—typically, just the normal dosage.

Federal laws and regulations clearly allow physicians to prescribe any marketed drug in any dosage and indication they deem appropriate. The use of drugs in so-called “off-label” fashion is commonplace in medical practice and is, in fact, so common and routine that physicians and hospitals may not even recognize that off-label prescribing is taking place. Common examples include prescribing antidepressants and antihistamines for sleep, antibiotics for acne, seizure drugs for migraine, and anti-hypertensives for drug withdrawal. The FDA and US Drug Enforcement Agency (DEA) are cognizant of this practice and are aware that it has been a tradition in medical practice for decades.

“Off-Label” Use In Pain Treatment
Physicians who treat pain problems extensively use numerous drugs “off-label.” In fact, off-label use is so common that it is difficult to imagine whether pain treatment would be very effective if such prescribing were not possible. Table 1 lists some of the common off-label prescribing practiced in pain treatment. Review the Table and ask yourself what would happen to pain practice if off-label use were suddenly banned.

Please refer to the May 2007 issue for the complete text. In the event you need to order a back issue, please click here.

— May 2007

The full article is now available as a PDF and may be
purchased for $5 and downloaded immediately:
Order Now


©2007 Copyright. PPM Communications, Inc. All rights reserved.